15.38
Avantor Inc stock is traded at $15.38, with a volume of 7.72M.
It is up +4.20% in the last 24 hours and up +7.85% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$14.76
Open:
$14.72
24h Volume:
7.72M
Relative Volume:
0.81
Market Cap:
$10.40B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-19.03
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
-3.03%
1M Performance:
+7.85%
6M Performance:
+98.97%
1Y Performance:
+28.06%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
15.38 | 10.40B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
A Look at Avantor Inc (AVTR) After 4.2% Gain -- GF Value $16.87 vs Price $15.38 - GuruFocus
Avantor stock falls 1.20 percent as new CFO takes office - AD HOC NEWS
Avantor, Inc. (AVTR) Stock Forecasts - finance.yahoo.com
Form 4 Avantor Inc For: 23 September By Investing.com - Investing.com Canada
At $16.61 a share, Avantor (AVTR) grants its CFO options that begin vesting in 2027. - Stock Titan
[Form 3] Avantor, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
How Avantor’s New CFO Appointment At Avantor (AVTR) Has Changed Its Investment Story - Yahoo Finance
Avantor Appoints Todd Garner as New Chief Financial Officer - The Globe and Mail
Avantor stock reacts as new CFO Todd Garner steps in - AD HOC NEWS
Form 8K Avantor Inc For: 21 September By Investing.com - Investing.com Nigeria
Avantor (NYSE: AVTR) Appoints Todd Garner as CFO with $700K Salary and $1.5M Equity Award - Kalkine Media
Avantor Appoints Todd Garner as Executive Vice President and CFO with Detailed Compensation Package - Kalkine Media
Are Medical Stocks Lagging Avantor (AVTR) This Year? - finance.yahoo.com
Avantor Names Todd Garner CFO to Lead Global Finance Organization - citybiz
Avantor names Todd Garner as chief financial officer By Investing.com - Investing.com Australia
Avantor Appoints New Chief Financial Officer - TradingView
Avantor, Inc. Appoints Todd Garner as Executive Vice President Effective September 21, 2026 - marketscreener.com
Avantor (AVTR) hires new CFO with seven-figure stock grants - Stock Titan
Avantor Names Todd Garner as CFO - finance.yahoo.com
Avantor names Todd Garner as new CFO to lead gl... - Pluang
Avantor names Todd Garner as chief financial officer - Investing.com
Avantor appoints new Chief Financial Officer - AOL.ca
Avantor (AVTR) Appoints New Chief Financial Officer - TradingView
Avantor, Inc. (AVTR) Stock Analysis: Navigating Opportunities In The Healthcare Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy? - Eastern Progress
Avantor Stock Price Forecast. Should You Buy AVTR? - StockInvest.us
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC - finance.yahoo.com
Avantor Inc (AVG) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Avantor expands RIM single-use portfolio of bioprocessing solutions across APAC - BioSpectrum Asia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Avantor Inc stock hits 52-week high at 15.94 USD By Investing.com - Investing.com Nigeria
Avantor Inc stock hits 52-week high at 15.94 USD - Investing.com
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Avantor, Inc. (NYSE:AVTR) Expands RIM Single-Use Portfolio Across APAC - TradingView
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Zacks Investment Research
Avantor Stock Has Strong Technical Momentum, But Make Sure Your Stop Losses Are Tight - Yahoo Finance
Avantor, Inc. (AVTR) Stock Analysis: Navigating a Competitive Healthcare Landscape with Cautious Optimism - directorstalkinterviews.com
ETFs Investing in Avantor, Inc. Stocks - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
(AVTR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
UBS Adjusts Avantor Price Target to $16 From $10.50, Maintains Neutral Rating - finance.yahoo.com
Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98 - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - accessnewswire.com
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Avantor stock gains as investors focus on recent earnings and valuation - AD HOC NEWS
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised - Eastern Progress
Is It Too Late to Buy Avantor Inc (AVTR) After 3.2% Rally? GF Va - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):